Breaking News

Inovalon Implements Platform Initiative for AstraZeneca

Aims to leverage combination of Avalere Business Unit and the Inovalon ONE Platform towards new value-based solutions

AstraZeneca has engaged Inovalon’s Avalere business unit to leverage the data and analytical capabilities of the Inovalon ONE® Platform to develop a comprehensive value-based platform to underpin the commercialization of an innovative therapy for the treatment of Chronic Obstructive Pulmonary Disease (COPD).   Under the agreement, industry subject matter experts within Inovalon’s Avalere business unit will leverage Inovalon’s extensive real-world datasets and analytics within the Inovalon ONE®...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters